Literature DB >> 27121784

Therapeutic Equivalence of Ursodeoxycholic Acid Tablets and Ursodeoxycholic Acid Capsules for the Treatment of Primary Biliary Cirrhosis.

Corinna Hopf1, Renate Grieshaber2, Heinz Hartmann3, Holger Hinrichsen4, Marc Eisold5, Hans-Jörg Cordes6, Roland Greinwald2, Christian Rust1.   

Abstract

Entities:  

Keywords:  cholestasis; clinical study; efficacy; liver enzymes; primary biliary cirrhosis; quality of life; ursodeoxycholic acid

Year:  2013        PMID： 27121784     DOI： 10.1002/cpdd.24

Source DB:  PubMed          Journal:  Clin Pharmacol Drug Dev        ISSN： 2160-763X


× No keyword cloud information.
  4 in total

Review 1.  Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases.

Authors:  Kareem Khalaf; Paolo Tornese; Antoniangela Cocco; Alberto Albanese
Journal:  Transl Neurodegener       Date:  2022-06-04       Impact factor: 9.883

Review 2.  Gene Therapy for Acquired and Genetic Cholestasis.

Authors:  Javier Martínez-García; Angie Molina; Gloria González-Aseguinolaza; Nicholas D Weber; Cristian Smerdou
Journal:  Biomedicines       Date:  2022-05-26

Review 3.  Emerging therapies for PBC.

Authors:  David Maxwell Hunter Chascsa; Keith Douglas Lindor
Journal:  J Gastroenterol       Date:  2020-01-22       Impact factor: 7.527

4.  A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis.

Authors:  Larissa Akeme Nakano; Eduardo Luiz Rachid Cançado; Cleuber Esteves Chaves; Maria Cristina Vaz Madeira; Jéssica Toshie Katayose; Mariana Akemi Nabeshima; Victor Fossaluza; Gabriela Guimarães Uhrigshardt; Zheng Liting; Vanusa Barbosa Pinto; Flair José Carrilho; Suzane Kioko Ono
Journal:  BMC Gastroenterol       Date:  2020-08-05       Impact factor: 3.067
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.